Sumitomo Mitsui Trust Group’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-467,018
Closed -$11.9M 1183
2022
Q4
$11.9M Sell
467,018
-620,066
-57% -$18.4M 0.01% 774
2022
Q3
$39.6M Buy
1,087,084
+11,047
+1% +$479K 0.03% 548
2022
Q2
$51.5M Buy
1,076,037
+111,440
+12% +$5.17M 0.04% 501
2022
Q1
$51M Buy
964,597
+52,982
+6% +$2.79M 0.03% 529
2021
Q4
$46.8M Sell
911,615
-1,046,414
-53% -$61.7M 0.03% 559
2021
Q3
$130M Sell
1,958,029
-128,468
-6% -$10M 0.08% 269
2021
Q2
$192M Buy
2,086,497
+128,585
+7% +$12.7M 0.11% 205
2021
Q1
$238M Buy
1,957,912
+367,009
+23% +$61M 0.15% 156
2020
Q4
$244M Buy
1,590,903
+186,263
+13% +$26.3M 0.16% 143
2020
Q3
$182M Buy
1,404,640
+98,613
+8% +$13M 0.12% 183
2020
Q2
$147M Buy
1,306,027
+74,525
+6% +$7.65M 0.1% 216
2020
Q1
$93.8M Buy
1,231,502
+585,053
+91% +$54.2M 0.08% 267
2019
Q4
$65.6M Buy
646,449
+144,884
+29% +$14.4M 0.05% 385
2019
Q3
$51.2M Buy
501,565
+336,880
+205% +$34.3M 0.04% 434
2019
Q2
$19.1M Buy
164,685
+161,459
+5,005% +$17.4M 0.02% 661
2019
Q1
$339K Buy
+3,226
New +$362K ﹤0.01% 927

Other funds holding PRLB

Sumitomo Mitsui Trust Group's PRLB Position: Q1 2023 in Review

Sumitomo Mitsui Trust Group sold out of Protolabs (PRLB) in Q1 2023, closing a stake of 467,018 shares — an estimated $11.9M sold.

Sumitomo Mitsui Trust Group first reported a position in PRLB in Q1 2019 and held it in 16 quarters. The position peaked at $244M in Q4 2020. 198 funds tracked by Wall St. Rank hold PRLB as of Q1 2023.

  • Sumitomo Mitsui Trust Group reported no remaining Protolabs position as of Q1 2023 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 467,018 Protolabs shares in Q1 2023, an estimated $11.9M.
  • Sumitomo Mitsui Trust Group first reported a position in Protolabs in Q1 2019 and held it in 16 quarters.
  • Sumitomo Mitsui Trust Group's Protolabs position peaked at $244M in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Protolabs as of Q1 2023.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2023, filed 27 Apr 2023.